INTEGRATION OF BIOSIMILAR THERAPIES IN ONCOLOGY AND HEMATOLOGY: REGULATORY, CLINICAL, AND PRACTICAL PERSPECTIVES
Johannes Lukas Schneider · January 2025 · pp. 14-27
The regulation of biosimilars is a process that is still developing. In Europe, guidance regarding the approval and use of biosimilars has evolved with the products under consideration. It is...